Stock Track | Omnicell Plunges 10.56% Pre-Market After Q4 Earnings Miss and Weak Guidance

Stock Track
Feb 05

Omnicell Inc. (OMCL) shares plummeted 10.56% in pre-market trading following the release of its fourth-quarter and full-year 2025 financial results.

The healthcare technology provider reported adjusted earnings per share of $0.40 for Q4 2025, missing the analyst consensus estimate of $0.50. While quarterly revenue of $314 million slightly exceeded expectations, the company posted a GAAP net loss of $2 million, reversing from a profit in the prior-year period.

Investors reacted negatively to the earnings miss and the company's outlook for fiscal year 2026, which includes adjusted EPS guidance of $1.65 to $1.85, below the consensus estimate of $1.88. The pre-market selloff reflects disappointment with both the quarterly performance and future earnings projections.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10